Background: Allergic reactions to ethylene oxide (EtO)-treated product
s have occurred in several children with myelomeningoceles. Objective:
The object of this study was to define the prevalence and significanc
e of EtO-specific IgE among the children in our myelomeningocele clini
c. Methods: The study population comprised three groups: children with
myelomeningoceles, chronically ill controls (defined as children who
had undergone at least three major operations), and well-child control
s. Serum specimens were collected from each child and a commercially a
vailable ELISA designed to identify, IgE directed against both EtO and
latex was performed on the specimens. Results: Seventeen of 75 (23%)
children with myelomeningoceles had antibodies directed against EtO, a
s did 1 of 26 (4%) chronically ill controls. None of the 25 well contr
ols had detectable levels of anti-EtO IgE. Children with antibodies di
rected against EtO were more likely to be atopic (p = 0.007) and to ha
ve a shunt (p = 0.021) and were markedly more likely to have antibodie
s directed against latex (p < 0.001). On average they had undergone mo
re shunt revisions and other operations than had children without anti
-EtO antibodies. Conclusion: During the period of study no child had a
naphylaxis thought to have been due to EtO exposure.